Navigation Links
Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder
Date:9/23/2008

one or more of these symptoms, contact your primary care physician. You may be need to be screened for a bleeding disorder.

For more information on VWD visit the Project Red Flag web site at http://www.projectredflag.org or call the National Hemophilia Foundation's Information Resource Center at 1-800-42-HANDI (email to handi@hemophilia.org). Trained staff members are available Monday through Friday, 9 a.m. to 5:00 p.m. EST to answer your requests.

About the National Hemophilia Foundation and Project Red Flag

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education, advocacy and research.

Established in 1948, the National Hemophilia Foundation is a non profit 501(c)3 organization with chapters throughout the country. Its programs and initiatives are made possible through the generosity of individuals, corporations and foundations as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC).

For more information about the National Hemophilia Foundation visit http://www.hemophilia.org.

About CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. Passionate about improving the quality of patients' lives, CSL Behring manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the treatment of immune deficiency disorders, hemophilia, von Willebrand disease, other bleeding disorders and inherited emphysema. Products include Humate P(R) Antihemophilic Factor/von Willebrand Factor Complex (Human) Dried, Pasteurized, for the treatment of von Willebrand Disease, and Helixate(R) FS a recombinant factor VIII treatment
'/>"/>

SOURCE National Hemophilia Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Video: Fortune 1000 Executives: New President Must Fix Education Gap
2. Video: Keppra XR(TM) Approved in the U.S.
3. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
4. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
5. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
6. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
7. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
8. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
9. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
10. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
11. Yongye Biotechnology International Raises $9.4 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email: